Two infusions of natalizumab (300 mg or 3 mg/kg) vs placebo
Faliure to induce clinical response at 8 weeks · Patients with active Crohn's disease
Two infusions of natalizumab (300 mg or 3 mg/kg) may leads to lower faliure to induce clinical response at 8 weeks compared with placebo (low certainty).
1 finding from 1 review
- RR 0.73 [0.58, 0.91]3 studies · 1543 participantsLow